TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show

benzinga.com/general/biotech/25/05/45207987/tg-therapeutics-falls-short-on-earnings-but-briumvi-sales-steal-the-show

TG Therapeutics Inc (NASDAQ:TGTX) on Monday reported first-quarter earnings per share of 3 cents, a shift from a loss of 7 cents a year ago, but below the consensus of 17 cents.
The company reported sales of $120.86 million, up from $63.47 million a year ago, beating the consensus of…

This story appeared on benzinga.com, 2025-05-05 20:37:15.
The Entire Business World on a Single Page. Free to Use →